Zum Inhalt springen
- {{#headlines}}
- {{title}} {{/headlines}}
Profil
| Derzeitige Stellung | Professor W-3 und Äquivalente |
|---|---|
| Fachgebiet | Organische Molekülchemie,Pharmazie |
| Keywords | Doking Study, Anticancer, Biological Activity, Synthesis, 4-Nitroimidazole |
| Auszeichnungen | 2011: Abdul Hameed Shoman Award For Young Arab Researchers 2009: Scopus (ELSEVIER) award in recognition for contribution to science 2005: The Al al-Bayt University Distinguished Professor Award 1994: Ph.D. Scholarship from German Academic Exchange Service (DAAD) |
Aktuelle Kontaktadresse
| Land | Jordanien |
|---|---|
| Ort | Mafraq |
| Universität/Institution | Al Al-Bayt University |
| Institut/Abteilung | Chemistry Department |
| Website | http://web2.aabu.edu.jo/staff.jsp?id=4&emp=1571&dept=403 |
Gastgeber*innen während der Förderung
| Prof. Dr. Rolf W. Hartmann | Lehrstuhl für Pharmazeutische und Medizinische Chemie, Universität des Saarlandes, Saarbrücken |
|---|---|
| Prof. Dr. Dr. h.c. Holger Stark | Institut für Pharmazeutische und Medizinische Chemie, Heinrich-Heine-Universität Düsseldorf, Düsseldorf |
| Beginn der ersten Förderung | 01.08.2007 |
Programm(e)
| 2007 | Humboldt-Forschungsstipendien-Programm |
|---|
Publikationen (Auswahl)
| 2024 | Al-Soud, Y. A.; Al-Sawakhneh, S.O.; Al-Qawasmeh, R.A.; Al-Masoudi, N.A.; Al-Ahmad A. H. ; Al-Maliki, L.; van Geelen, L.; Kalscheuer, R.; Saeed, B. A.; Shtaiwi, A.; and Stark, H. Novel 4-nitroimidazole analogues: Synthesis, in vitro biological evaluation, in silico studies and molecular dynamics simulation. In: Z. Natufrorschung C, 79 2024, 61-71 |
|---|---|
| 2012 | Yaseen A. Al-Soud, Sandrine Marchais-Oberwinkler, Patricia Kruchten, Martin Frotscher and Rolf W. Hartmann : Synthesis and Biological Evaluation of Hydroxyphenyl Substituted 1,2,4-Triazoles as Non-Steroidal Inhibitors of 17beta-Hydroxysterid Dehydrogenase Type 1 (17beta-HSD1). In: Arch. Pharm. Chem. Life Sci., 2012, 610-621 |
| 2011 | Yaseen A. Al-Soud, Michael Heydel and Rolf W. Hartmann Design and synthesis of 1,3,5-trisubstituted 1,2,4-triazoles as CYP enzyme inhibitors. In: Tetrahedron Letters, 2011, 6372-6375 |
| 2011 | Kuiying Xu, Yaseen A. Al-Soud, Marie Wetzel, Rolf W. Hartmann, Sandrine Marchais-Oberwinkler: Triazole ring-opening leads to the discovery of potent nonsteroidal 17beta-hydroxy steroid dehydrogenase type 2 inhibitors. In: European Journal of Medicinal Chemistry , 2011, 5978-5990 |
| 2009 | Al-Soud, Y.A.; Bey, E.; Alexander, O.; Marchais-O., S.; Werth, R.; M., Kruchten, P.; Frotscher, M. and Hartmann, R.W. : The Role of the Heterocycle in Bis(hydroxyphenyl)triazoles for Inhibition of 17-[beta]-Hydroxysteroid Dehydrogenase (17[beta]-HSD) Type 1 and Type 2 . In: Molecular and Cellular Endocrinology, 2009, 212-215 |
| 2008 | Emmanuel Bey, Sandrine Marchais-Oberwinkler, Ruth Werth, Matthias Negri, Yaseen A. Al-Soud, Patricia Kruchten, Alexander Oster, Martin Frotscher, Barbara Birk, and Rolf W. Hartmann: Design, Synthesis, Biological Evaluation and Pharmacokinetics of Bis(hydroxyphenyl) substituted Azoles, Thiophenes, Benzenes, and Aza-Benzenes as Potent and Selective Nonsteroidal Inhibitors of17[beta]-Hydroxysteroid Dehydrogenase Type 1 (17[beta]-HSD1). In: Journal of Medicinal Chemistry, 2008, 6725-6739 |